KMXBIO LLC – Trademark Portfolio
Entity Type: 99
KMXBIO LLC has 5 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 4 are successfully registered — a 100% registration rate, with 1 application currently pending. The portfolio includes marks such as KINGMAX and WINLIFE. Filings span 6 Nice Classification classes, with the highest activity in Class 5 (Pharmaceuticals) and Class 25 (Clothing). This trademark owner is based in SAN DIMAS, CA.
170 E ARROW HWY
SAN DIMAS, CA 91773
Showing of trademarks Trademarks
Trademark Classifications
KMXBIO LLC's trademark portfolio spans 6 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Precious metals and their alloys; jewellery, precious stones; horological instruments
Leather and imitations of leather; animal skins, hides; trunks and travelling bags
Frequently Asked Questions
How many trademarks does KMXBIO LLC have?
KMXBIO LLC has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does KMXBIO LLC file in?
KMXBIO LLC files trademarks across 6 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 3 (Cosmetics & Cleaning), Class 14 (Jewelry), Class 18 (Leather Goods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are KMXBIO LLC's most well-known trademarks?
KMXBIO LLC's registered trademark portfolio includes well-known marks such as KINGMAX and WINLIFE. These are among 4 currently registered trademarks in the portfolio.
What is KMXBIO LLC's trademark registration success rate?
KMXBIO LLC has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.